Cosentini, Deborah
 Distribuzione geografica
Continente #
NA - Nord America 1.523
EU - Europa 874
AS - Asia 127
AF - Africa 3
SA - Sud America 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.533
Nazione #
US - Stati Uniti d'America 1.514
PL - Polonia 313
IT - Italia 128
CN - Cina 90
IE - Irlanda 87
DE - Germania 86
UA - Ucraina 86
FI - Finlandia 46
BE - Belgio 36
GB - Regno Unito 31
SE - Svezia 29
VN - Vietnam 28
FR - Francia 20
CA - Canada 9
IN - India 5
NL - Olanda 5
RU - Federazione Russa 5
CL - Cile 2
ZW - Zimbabwe 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
HK - Hong Kong 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.533
Città #
Warsaw 313
Fairfield 276
Chandler 158
Ashburn 115
Seattle 111
Woodbridge 111
Houston 106
Wilmington 79
Cambridge 78
Jacksonville 76
Princeton 73
Helsinki 45
Ann Arbor 44
Dublin 44
Brussels 36
Brescia 29
Dong Ket 28
Beijing 26
Menlo Park 23
Dearborn 20
Nanjing 16
Naples 14
San Diego 13
Des Moines 11
London 9
Milan 8
Nanchang 8
Rome 8
Changsha 6
Jinan 6
San Francisco 6
Perugia 5
Shenyang 5
Tianjin 5
Hebei 4
Livorno 4
Phoenix 4
Redwood City 4
Guangzhou 3
Hanover 3
North York 3
Norwalk 3
Rockville 3
Augusta 2
Bergamo 2
Berlin 2
Borås 2
Brooklyn 2
Chicago 2
Chiswick 2
Fuzhou 2
Gunzenhausen 2
Huizen 2
Leawood 2
Leipzig 2
Ottawa 2
Pianello del Lario 2
Quarrata 2
Rochester 2
Taizhou 2
Toronto 2
Würzburg 2
Zhengzhou 2
Amsterdam 1
Arcore 1
Ardabil 1
Bengaluru 1
Bratislava 1
Cairate 1
Campogalliano 1
Caserta 1
Cinisello Balsamo 1
Dallas 1
Delhi 1
Durham 1
Florence 1
Fremont 1
Gardone Val Trompia 1
Gavardo 1
Huzhou 1
Hyderabad 1
Iseo 1
Kunming 1
Lanzhou 1
Lappeenranta 1
Melbourne 1
Monza 1
Mumbai 1
Napoli 1
New Bedfont 1
New York 1
Ningbo 1
Pignone 1
Québec 1
Redmond 1
San Donà Di Piave 1
Santiago 1
Tirana 1
Travagliato 1
Venice 1
Totale 2.019
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 165
null 158
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 149
Immunotherapy failure in adrenocortical cancer: where next? 147
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 142
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 135
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 134
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 105
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 104
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 100
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 94
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 88
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 81
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 76
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 76
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 74
Transformation of prostate adenocarcinoma into small-cell neuroendocrine cancer under androgen deprivation therapy: Much is achieved but more information is needed 73
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 66
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 53
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device 45
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 39
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy 37
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 32
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 31
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 31
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 29
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 25
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 23
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 23
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 22
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 19
Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019-2021 19
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 19
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 17
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 17
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 17
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 16
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 12
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 12
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 12
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 12
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 12
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question 11
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 9
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 7
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 7
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 7
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 6
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 6
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review 5
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 4
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 4
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 2
Eight-week interval in flushing and locking port-a-cath in cancer patients: A single-institution experience and systematic review 2
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 2
Is it time to tailor treatments in androgen receptor positive salivary gland cancers? 1
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 1
Totale 2.615
Categoria #
all - tutte 12.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.069


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019147 0 0 0 3 12 5 10 13 4 18 39 43
2019/2020679 47 18 21 63 53 82 75 79 66 70 47 58
2020/2021768 35 88 72 91 67 74 32 68 48 88 38 67
2021/2022416 37 10 12 89 19 27 15 21 17 55 32 82
2022/2023461 52 22 27 31 36 99 5 52 59 17 33 28
2023/2024140 45 33 62 0 0 0 0 0 0 0 0 0
Totale 2.615